Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 866 402 4033

New Drug Approvals

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


August 19th, 2009
Gaucher Treatment Drug prGCD Newly Approved

Although, prGCD, a new drug used to treat patients with a unique genetic disorder - Gaucher disease, has not received full market approval, the U.S. FDA has said that physicians may utilize the drug for treatment.

August 17th, 2009
FDA Endorses Multiple Sclerosis Treatment, Extavia

Novartis has recently announced the U.S. FDA approval of their multiple sclerosis treatment drug: Extavia (Interferon beta 1-b). The FDA approved the drug for patients that suffer from a relapse of the auto immune disease, or for those patients whom are newly diagnosed with MS.

August 17th, 2009
Saphris Sublingual Tabs Receives FDA Endorsement

The US FDA has approved Saphris sublingual tablets for the acute therapy of schizophrenic adults, as well as the acute therapy of manic or mixed bipolar I disorder, with or without adult psychotic attributes. Saphris is endorsed for first-line therapy, and is the first prescription drug to receive primary consent for both of these symptoms concurrently.

August 7th, 2009
Baxter Completes CELVAPAN A/H1N1 Pandemic Vaccine

Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine. Currently, Baxter is discussing distribution options with national health authorities, so long as they receive appropriate permission. Baxter implemented their proprietary Vero cell production technology when developing CELVAPAN.

August 7th, 2009
US FDA Supports Once-Daily Diabetes Treatment Onglyza

Recently, the US FDA has approved a once-daily tablet to treat adult Type 2 Diabetes. Along with diet and exercise, Onglyza will assist to manage high blood sugar levels.

August 7th, 2009
US FDA Supports Antipsychotic Once-Monthly Invega Sustenna

The US FDA has recently approved Invega Sustenna extended-release injectable suspension for acute and maintenance therapy of adult schizophrenia. Invega Sustenna is the first US approved once a month injectable, long-acting, atypical antipsychotic.

August 6th, 2009
2009 – 2010 Seasonal Influenza Vaccine approved by FDA

The US FDA has reported seasonal influenza vaccine approval for 2009 and 2010.

August 6th, 2009
Onsolis Slated to be Marketed After FDA Approval

The US FDA has officially announced their approval to market Onsolis, an advanced treatment used for the management of breakthrough pain, for cancer patients over the age of eighteen, who already receive and have built a tolerance to opiod therapy for unrelenting cancer pain

August 6th, 2009
FDA Signs Off on Plan B One-Step Emergency Contraceptive

Women who experience contraceptive failure or who have engaged in unprotected sex, may be relieved to know that Teva Pharmaceuticals Inc. has announced that the U.S. Food and Drug Administration (FDA) has recently approved a New Drug Application for Plan B, One- Step Emergency Contraceptive.

  • Page 2 of 2
  • <
  • 1
  • 2


Search for Medication or Types of Conditions



: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

download order form


Medicine Shoppe Pharmacy
148 #9 31205 Maclure Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan


TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930